startup 🚀
domain
Health
#
Healthcare & Wellness
Growth & Investment
Mirscience Therapeutics develops RNA-based oligonucleotides to treat age-related diseases. Our lead candidate, MT-29, targets key genes in sarcopenia using a proprietary platform that combines RNA biology and AI to unlock non-coding RNA therapeutics.
Hosted by